title: Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.
abstract: To investigate the differences in gene expression level between metastatic and non-metastatic osteosarcoma (OS) samples and the potential mechanism. Gene expression profile data GSE9508 were downloaded from Gene Expression Omnibus database to identify the differentially expressed genes (DEGs) between metastatic, non-metastatic OS samples, and normal control samples via SAM method. Function expression matrix of the DEGs was constructed by calculating the functional node scores based on the genes sets collected from the pathways recorded in MsigDB database. Next, t test was applied to screen the differentially expressed functional nodes between each two kinds of samples. Finally, we compared the significant genes between selected DEGs and genes in differentially expressed functional nodes. There were 79 up-regulated DEGs between non-metastatic OS and normal samples, 380 up-regulated and 134 down-regulated DEGs between the metastatic OS and normal samples, and 761 up-regulated plus 186 down-regulated DEGs between metastatic and non-metastatic OS samples. A total of 3846 functional gene sets were collected to form the function expression profile matrix. The numbers of differentially expressed functional nodes between non-metastatic OS and normal samples, metastatic OS and normal samples, and metastatic and non-metastatic OS samples were 8, 39, and 5, respectively. The gene level difference between metastatic and non-metastatic OS samples can be distinguished using bioinformatics analysis. TGFB1, LFT3, KDM1A, and KRAS genes have the potential to be used as biomarkers for OS; however, further analysis is needed to verify the current results.
authors.affiliation: Department of Bone and Soft Tissue Tumor, Shandong Cancer Hospital and Institute, Ji Yan Road No. 440, Jinan, 250117, China, baoyongsunbys@163.com.
authors.forename: Baoyong
authors.initials: B
authors.lastname: Sun
authors.forename: Fangxin
authors.initials: F
authors.lastname: Wang
authors.forename: Min
authors.initials: M
authors.lastname: Li
authors.forename: Mingshan
authors.initials: M
authors.lastname: Yang
mesh_terms: D001859:Bone Neoplasms / Q000235:genetics* / Q000473:pathology; D019295:Computational Biology / Q000379:methods; D015536:Down-Regulation / Q000235:genetics; D020869:Gene Expression Profiling / Q000379:methods; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D006801:Humans; D009362:Neoplasm Metastasis / Q000235:genetics*; D012516:Osteosarcoma / Q000235:genetics* / Q000473:pathology; D059467:Transcriptome / Q000235:genetics*; D015854:Up-Regulation / Q000235:genetics
references.citation: J Surg Oncol. 2008 Nov 1;98(6):415-20
references.pmid: 18792969
references.citation: Stem Cells. 2013 Mar;31(3):433-46
references.pmid: 23225703
references.citation: Cancer Res. 2005 Mar 15;65(6):2170-8
references.pmid: 15781628
references.citation: J Clin Invest. 2013 Nov;123(11):4681-94
references.pmid: 24216479
references.citation: J Clin Oncol. 2005 Jun 1;23(16):3742-51
references.pmid: 15923571
references.citation: Antimicrob Agents Chemother. 2004 Aug;48(8):2838-44
references.pmid: 15273089
references.citation: Genome Inform. 2004;15(1):239-48
references.pmid: 15712126
references.citation: Cell Biol Toxicol. 2012 Aug;28(4):201-12
references.pmid: 22422053
references.citation: AMIA Annu Symp Proc. 2012;2012:1040-9
references.pmid: 23304380
references.citation: Anticancer Drugs. 2012 Jan;23(1):108-18
references.pmid: 21946058
references.citation: Cancer Treat Res. 2009;152:3-13
references.pmid: 20213383
references.citation: J Pediatr Hematol Oncol. 2013 Jan;35(1):54-60
references.pmid: 23128330
references.citation: Prostate. 2009 Aug 1;69(11):1222-34
references.pmid: 19434660
references.citation: J Bioinform Comput Biol. 2003 Oct;1(3):459-74
references.pmid: 15290765
references.citation: Hum Pathol. 2012 Aug;43(8):1300-7
references.pmid: 22245111
references.citation: Expert Rev Mol Diagn. 2010 Jan;10(1):49-64
references.pmid: 20014922
references.citation: Behav Brain Res. 2001 Nov 1;125(1-2):279-84
references.pmid: 11682119
references.citation: Front Genet. 2013 May 31;3:160
references.pmid: 23755061
references.citation: Cancer Res. 2010 Sep 15;70(18):7063-72
references.pmid: 20823153
references.citation: PLoS Comput Biol. 2012 Jan;8(1):e1002350
references.pmid: 22291585
references.citation: Cancer. 1997 Jan 15;79(2):245-54
references.pmid: 9010097
references.citation: Oncologist. 2004;9(4):422-41
references.pmid: 15266096
references.citation: Brief Bioinform. 2011 Sep;12(5):498-513
references.pmid: 21156727
references.citation: Cancer Metastasis Rev. 2009 Jun;28(1-2):247-63
references.pmid: 19214708